A detailed history of Adirondack Trust CO transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Adirondack Trust CO holds 860 shares of FLGT stock, worth $15,918. This represents 0.01% of its overall portfolio holdings.

Number of Shares
860
Previous 860 -0.0%
Holding current value
$15,918
Previous $16,000 12.5%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 05, 2022

BUY
$49.85 - $96.11 $6,480 - $12,494
130 Added 17.81%
860 $54,000
Q4 2021

Jan 13, 2022

BUY
$77.3 - $105.0 $4,638 - $6,300
60 Added 8.96%
730 $73,000
Q1 2021

Apr 16, 2021

BUY
$59.3 - $183.85 $2,965 - $9,192
50 Added 8.06%
670 $65,000
Q4 2020

Feb 12, 2021

BUY
$31.01 - $52.1 $19,226 - $32,302
620 New
620 $69,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $560M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Adirondack Trust CO Portfolio

Follow Adirondack Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adirondack Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Adirondack Trust CO with notifications on news.